Certain information has been excluded because it both (i) is not material and (ii) is the type the Company treats as private or confidential] SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 20th, 2025 • CV Sciences, Inc. • Pharmaceutical preparations • Delaware
This Securities Purchase Agreement (this “Agreement”) is dated as February 12, 2025, among CV Sciences, Inc., a Delaware corporation whose principal place of business is located at 9530 Padgett Street, Suite 107, San Diego, CA 92126 (the “Company”) and the Purchaser identified on the signature pages hereto (including its successors and assigns, the “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 26th, 2022 • Jupiter Neurosciences, Inc. • Pharmaceutical preparations • Delaware
This Securities Purchase Agreement (this “Agreement”) is dated as April 11, 2022, among Jupiter Neurosciences, Inc, a Delaware corporation whose principal place of business is located at 1001 North US Hwy 1, Suite 504, Jupiter, Florida 33477 (the “Company”) and the Purchaser identified on the signature pages hereto (including its successors and assigns, the “Purchaser”).